Cargando…
Neuroimmune disorders in COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the aetiologic agent of the coronavirus disease 2019 (COVID-19), is now rapidly disseminating throughout the world with 147,443,848 cases reported so far. Around 30–80% of cases (depending on COVID-19 severity) are reported to have neurol...
Autores principales: | Ariño, Helena, Heartshorne, Rosie, Michael, Benedict D., Nicholson, Timothy R., Vincent, Angela, Pollak, Thomas A., Vogrig, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120100/ https://www.ncbi.nlm.nih.gov/pubmed/35353232 http://dx.doi.org/10.1007/s00415-022-11050-w |
Ejemplares similares
-
Characterising neuropsychiatric disorders in patients with COVID-19 – Authors' reply
por: Varatharaj, Aravinthan, et al.
Publicado: (2020) -
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders
por: De Marchi, Fabiola, et al.
Publicado: (2023) -
Hypotheses on the neuroimmune cross-talk between COVID-19 and neuropsychiatric disorders
por: Senra, Hugo
Publicado: (2021) -
Neuroimmune Regulation of Surgery-Associated Metastases
por: Shurin, Michael R., et al.
Publicado: (2021) -
Neuroimmune-vascular cells and their pathological disorders
por: Mantione, Kirk J.
Publicado: (2011)